Literature DB >> 32417794

Parkinson's Disease in African Americans: A Review of the Current Literature.

Meagan Bailey1, Sharlet Anderson1, Deborah A Hall1.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, though evidence suggests that this disorder does not affect all racial groups similarly. Research in African Americans, in particular, has been conflicting. Some studies have found similar prevalence rates in African Americans and whites whereas other studies have found much lower prevalence and incidence rates in African Americans. A few studies identify potential factors underlying these discrepancies, including biologic differences as well as disparities in healthcare access. However, African Americans remain underrepresented in research studies, which make understanding the underlying reasons for these differences difficult. The purpose of this paper is to summarize existing research in African Americans with PD, highlight some of the reasons why differences exist in diagnostic rates of PD in this population, and briefly discuss interventions that may need to be made in order to ensure adequate care is provided to these patients.

Entities:  

Keywords:  African Americans; Parkinson’s disease; epidemiology; healthcare disparities

Year:  2020        PMID: 32417794     DOI: 10.3233/JPD-191823

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  5 in total

1.  Exploring the experiences of people and family carers from under-represented groups in self-managing Parkinson's disease and their use of digital health to do this.

Authors:  Danielle Nimmons; Megan Armstrong; Jennifer Pigott; Kate Walters; Anette Schrag; Della Ogunleye; Wesley Dowridge; Joy Read; Nathan Davies
Journal:  Digit Health       Date:  2022-05-26

2.  Genetic ancestry in precision medicine is reshaping the race debate.

Authors:  Talia Krainc; Agustín Fuentes
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-16       Impact factor: 12.779

Review 3.  Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies.

Authors:  Pedro Magalhães; Hilal A Lashuel
Journal:  NPJ Parkinsons Dis       Date:  2022-07-22

4.  Persistent Racial Disparities in Deep Brain Stimulation for Parkinson's Disease.

Authors:  Samuel W Cramer; Truong H Do; Elise F Palzer; Anant Naik; Abigail L Rice; Savannah G Novy; Jacob T Hanson; Amber N Piazza; Madeleine A Howard; Jared D Huling; Clark C Chen; Robert A McGovern
Journal:  Ann Neurol       Date:  2022-05-10       Impact factor: 11.274

5.  A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson's Research and Care.

Authors:  Bernadette Siddiqi; Andrew Koemeter-Cox
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.